Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Reports First Quarter 2020 Results
GAAP and non-GAAP revenues of $229.7 million , up 13.4% year-over-year GAAP net income per diluted share of $0.26 , up 225.0% year-over-year Non-GAAP net income per diluted share of $0.66 , up 8.2% year-over-year Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Hold Virtual 2020 Annual Meeting of Stockholders
Event Webcast Scheduled for Tuesday, May 26 MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--May 1, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that due to the public health impact of...
View HTML
Toggle Summary Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Apr. 28, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, May 7, 2020 , to discuss the Company’s First Quarter 2020...
View HTML
Toggle Summary Geisinger Optimizes Hospital Efficiency and Safety with Continued Investment in Omnicell XT Series Automated Dispensing Systems
Automating and securing the medication dispensing system throughout the hospital streamlines nursing workflow and helps improve patient care MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 10, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence...
View HTML
Toggle Summary Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted share of $2.81 Record ending product backlog of $588 million MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 6, 2020-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell Enhances Robotic IV Insourcing Offerings and Ramps up Investment in IV Automation Technology
Recent severe challenges in 503B supply creating need for novel, more reliable, and safer alternatives MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 3, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and...
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 30, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020 , to discuss the Company’s Fourth Quarter...
View HTML
Toggle Summary Multiple Health Systems Help Optimize Efficiency and Patient Safety by Adopting Omnicell’s Point of Care Automated Workflow Technology
Smart medication management – using automation and data intelligence – is transforming patient care in hospitals across the U.S. MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 28, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for...
View HTML
Toggle Summary Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding
Central Pharmacy IV Compounding Service creates a safer, more accurate and cost-effective IV pharmacy MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 21, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies,...
View HTML
Toggle Summary Omnicell to Present at the 38th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 18, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
View HTML